MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$14,112K
Free Cash flow
-$15,661K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from maturities and red...
Stock-based compensation expense
Accounts payable
Others
Negative Cash Flow Breakdown
Net loss
Purchases of long-term investmen...
Accounts receivable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-23,403
-21,895
-13,466
-14,209
Depreciation expense
709
585
538
385
Provision for expected credit losses
16
-
16
24
Stock-based compensation expense
7,016
5,406
4,303
4,478
Net provision (recovery) for excess and obsolete inventory
23
-202
854
435
Change in fair value of warrant liabilities
-
-
0
0
Accretion of discount on short-term investments
-
-
-29
-316
Accretion of discount on long-term investments
-
-
-
17
Amortization of premium on long-term investments
-
-
63
-
Amortization of premium (discount) on short-term and long-term investments
95
86
-
-
Amortization of operating lease right-of-use asset
409
402
397
298
Loss on disposal of property and equipment
-
-
-31
-
Accounts receivable
2,319
-1,368
5,595
168
Inventories
214
1,803
2,203
3,327
Prepaid expenses and other current assets
-415
-951
413
1,790
Other long-term assets
-40
1
-3
39
Accounts payable
2,862
-3,333
527
1,100
Accrued expenses and other current liabilities
-222
-5,217
5,859
4,115
Other long-term liabilities
71
11
342
194
Operating lease liability
-400
-391
-384
-285
Deferred revenue
280
201
526
517
Net cash used in operating activities
-14,622
-23,832
-8,627
-8,729
Purchases of short-term investments
-
-
45,263
46,004
Purchases of long-term investments
20,028
24,784
176
14,228
Proceeds from maturities and redemptions of short-term investments
48,000
48,000
48,000
71,000
Purchases of property and equipment
1,039
1,377
1,903
1,282
Net cash (used in) provided by investing activities
26,933
21,839
658
9,486
Proceeds from the issuance of common stock, net of underwriting discounts, commissions and issuance costs
-
-
-904
0
Proceeds from the issuance of common stock from private placement, net of issuance costs
-
-
0
0
Proceeds from stock option exercises
-
623
1,964
2,653
Proceeds from stock option exercises and employee stock purchase plan issuances
2,424
-
-
-
Net cash provided by financing activities
1,801
623
1,060
2,653
Net increase in cash, cash equivalents and restricted cash
14,112
-1,370
-6,909
3,410
Cash, cash equivalents and restricted cash at beginning of period
30,306
31,676
38,585
30,532
Cash, cash equivalents and restricted cash at end of period
44,418
30,306
31,676
38,585
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from maturities
and redemptions of...
$48,000K
(-5.88%↓ Y/Y)
Proceeds from stock
option exercises and...
$2,424K
Net cash (used in)
provided by investing...
$26,933K
(115.57%↑ Y/Y)
Net cash provided by
financing activities
$1,801K
(-99.15%↓ Y/Y)
Canceled cashflow
$21,067K
Canceled cashflow
$623K
Net increase in
cash, cash...
$14,112K
(203.94%↑ Y/Y)
Canceled cashflow
$14,622K
Purchases of long-term
investments
$20,028K
(-35.54%↓ Y/Y)
Purchases of property and
equipment
$1,039K
(-50.80%↓ Y/Y)
Stock-based compensation
expense
$7,016K
(-7.72%↓ Y/Y)
Accounts payable
$2,862K
(507.64%↑ Y/Y)
Depreciation expense
$709K
(9.08%↑ Y/Y)
Prepaid expenses and
other current assets
-$415K
(-111.51%↓ Y/Y)
Amortization of operating
lease right-of-use...
$409K
(-32.62%↓ Y/Y)
Deferred revenue
$280K
(-72.33%↓ Y/Y)
Amortization of premium
(discount) on short-term...
$95K
Other long-term
liabilities
$71K
(-92.98%↓ Y/Y)
Other long-term
assets
-$40K
(-566.67%↓ Y/Y)
Net provision
(recovery) for excess and...
$23K
(-87.83%↓ Y/Y)
Provision for expected
credit losses
$16K
something is missing
-$623K
Net cash used in
operating activities
-$14,622K
(56.44%↑ Y/Y)
Canceled cashflow
$11,936K
Net loss
-$23,403K
(48.59%↑ Y/Y)
Accounts receivable
$2,319K
(485.86%↑ Y/Y)
Operating lease liability
-$400K
(29.45%↑ Y/Y)
Accrued expenses and
other current...
-$222K
(91.29%↑ Y/Y)
Inventories
$214K
(-95.08%↓ Y/Y)
Buy us a coffee
Beta Bionics, Inc. (BBNX)
Beta Bionics, Inc. (BBNX)